CompletedPhase 2

A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder

United States25 participantsStarted 2016-07

Plain-language summary

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ability and acceptance to provide written consent * Men or women between 18-75 years * Body Mass Index of ≥ 18 and ≤ 30 kg/m2 Exclusion Criteria: * History (within the 12 months prior to screening) of psychiatric disorders * Major surgery, trauma, illness or immobile for 3 or more days within the past month * Pregnancy or recent pregnancy (within 6 weeks) * A positive test for drugs of abuse at the screening visit * Any other sound medical reason as determined by the clinical investigator

What they're measuring

Total Sleep Time in the First Two-Thirds of the Night on the Night(s) Most Likely to be Disrupted

Timeframe: 4 days

Trial details

NCT IDNCT03291041

SponsorVanda Pharmaceuticals

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2017-11

Results submitted2020-09-25

View on ClinicalTrials.gov More Jet Lag Disorder trials